AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-13.5%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
-13.5%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20259.86%
202464.62%
2023-27.21%
2022-50.36%
202187.51%
202020.32%
2019-2.41%
20185.28%
201713.66%
201628.51%